mRNA Vaccine and Therapeutics: Paving the Way for Innovative Treatments
Roots Analysis
Market research & consulting services in the pharma / biopharma, medical devices & contract manufacturing domains
The global mRNA vaccine and therapeutics market size for Covid-19 is estimated to be worth US$9 billion in 2024. Further, mRNA vaccine and therapeutics market size for other indications is projected to be US$1.99 billion by 2035, representing a CAGR of 16% during the forecast period from 2026 to 2035.
Presently, several mRNA therapeutics and mRNA vaccines are being evaluated in various stages of clinical trials for the treatment of multitude of disease indications. While the primary focus lies on mRNA vaccines, mRNA therapeutic companies such as Moderna, BioNTech and Arcturus Therapeutics, are also engaged in actively developing mRNA therapeutics. Additionally, the companies are evaluating various mRNA delivery technologies in order to ensure efficient and safe delivery of mRNA-based drugs.
For detailed information:
Email: sales@rootsanalysis.com
Competitive Landscape of mRNA Vaccine and Therapeutics Developers Offering mRNA Drug Candidates
According to Roots Analysis, the mRNA vaccine and therapeutics market features the presence of over 45 mRNA vaccine and therapeutics developers. It is worth highlighting that around 30% of these companies are large and very large firms, indicating the presence of well-established players in this market.
Further, majority of these companies are headquartered in North America (~50%) followed by Europe and Asia-Pacific. It is worth highlighting that big pharma companies such as Merck, Sanofi and Daiichi Sankyo have partnered with smaller, dedicated mRNA-based therapeutic and vaccines developers to expand their respective capabilities in this upcoming field of therapy.
Recommended by LinkedIn
Trends Analysis: Partnerships, Funding, Clinical Trials and More
It is worth highlighting that close to 150 collaborations have been inked between industry / academic stakeholders to advance the development of their proprietary pipeline candidates. A number of big pharma companies have established the partnerships and have acted as active investors in emerging mRNA vaccine companies. The mRNA vaccine and therapeutics market has drawn huge investments, specifically in since 2020, over USD 5 billion was invested in mRNA therapeutics companies. The raised funds are not solely focused on the development of mRNA therapeutics for infectious diseases, but cancer focused mRNA drug development efforts have also generated interest amongst the venture community.
Since 2017, the number of clinical trials registered for evaluation of mRNA-based products increased at a compounded annual growth rate (CAGR) of more than 60%. This growth is driven by the development of COVID-19 vaccine and the entry of new mRNA therapeutics and mRNA vaccines into the clinical phase. Considering the growing interest of various stakeholders and encouraging clinical research results, the overall mRNA therapeutics and mRNA vaccines market is anticipated to witness consistent market growth during the forecast period.
Regional Analysis: North America Holds the Largest Market Share of mRNA Vaccine and Therapeutics Market; Asia Pacific to be the Fastest Growing Market
Presently, North America and Europe capture around 70% of the mRNA vaccine and therapeutics market size. However, in the coming years, owing to the anticipated improvement in the research and development activities for mRNA drug candidates in Asia Pacific, this region is likely to grow at a higher CAGR as compared to other regions.
All your Questions Related to mRNA Vaccine and Therapeutics Market Answered in this Report
The mRNA Vaccine and Therapeutics Market (3rd Edition), till 2035 report features extensive research of the current market landscape, market size, market forecast and future opportunities for the companies involved in the mRNA vaccine and therapeutics market. The report answers many key questions related to this market. Click on the below link to know more about this emerging area of research.
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.